Nanoviricides Inc (NNVC)
1.47
+0.06
(+4.26%)
USD |
NYAM |
Oct 04, 16:00
1.46
-0.01
(-0.68%)
After-Hours: 20:00
Nanoviricides Shareholders Equity (Annual): 11.46M for June 30, 2024
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
Date | Value |
---|---|
June 30, 2024 | 11.46M |
June 30, 2023 | 14.87M |
June 30, 2022 | 23.08M |
June 30, 2021 | 29.91M |
June 30, 2020 | 21.76M |
June 30, 2019 | 10.60M |
June 30, 2018 | 17.66M |
June 30, 2017 | 20.32M |
June 30, 2016 | 23.05M |
June 30, 2015 | 31.79M |
Date | Value |
---|---|
June 30, 2014 | 23.37M |
June 30, 2013 | 8.010M |
June 30, 2012 | 13.85M |
June 30, 2011 | 10.17M |
June 30, 2010 | 6.519M |
June 30, 2009 | 2.486M |
June 30, 2008 | 0.4437M |
June 30, 2007 | 0.5003M |
June 30, 2006 | 1.238M |
June 30, 2005 | -0.066M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
11.46M
Minimum
2024
29.91M
Maximum
2021
20.22M
Average
21.76M
Median
2020
Shareholders Equity (Annual) Benchmarks
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -0.1115M |
iBio Inc | 21.32M |
Theriva Biologics Inc | 39.70M |
Oragenics Inc | 3.168M |